Crossmark

Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors

Crossref DOI link: https://doi.org/10.1038/onc.2017.319

Published Online: 2017-09-11

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chan, J S K

Sng, M K

Teo, Z Q

Chong, H C

Twang, J S

Tan, N S
License Information

Text and Data Mining valid from 2017-09-11
More Information

Article History

Received: 5 December 2016

Revised: 29 July 2017

Accepted: 6 August 2017

First Online: 11 September 2017

Competing interests

: The authors declare no conflict of interest.